Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
08:54 AM, 5th Feb 2026
Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge New YorkInspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain